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Abstract Minimally invasive surgical techniques for gastric cancer are gaining more acceptance worldwide as an
alternative to open resection. In order to assess the role of minimally invasive and open techniques in total gastrectomy
for cancer, a systematic review and meta-analysis was performed. Articles comparing minimally invasive versus open
total gastrectomy were reviewed, collected from the Medline, Embase, and Cochrane databases. Two different authors
(JS and NW) independently selected and assessed the articles. Outcomes regarding operative results, postoperative
recovery, morbidity, mortality, and oncological outcomes were analyzed. Statistical analysis portrayed the weighted
mean difference (WMD) with a 95 % confidence interval and odds ratio (OR). Out of 1242 papers, 12 studies were
selected, including a total of 1360 patients, of which 592 underwent minimally invasive total gastrectomy (MITG).
Compared to open total gastrectomy (OTG), MITG showed a longer operation time (WMD: 48.06 min, P\ 0.00001),
less operative blood loss (WMD:-160.70 mL, P\ 0.00001), faster postoperative recovery, measured as shorter time
to first flatus (WMD-1.05 days, P\ 0.00001), shorter length of hospital stay (WMD:-2.43 days, P = 0.0002), less
postoperative complications (OR 0.66, P = 0.02), similar mortality rates (OR 0.60, P = 0.52), and similar rates in
lymph node yield (WMD -2.30, P = 0.06). Minimally invasive total gastrectomy showed faster postoperative
recovery and less postoperative complications, whereas completeness of the resection was similar in both groups.
Duration of surgery was longer in the minimally invasive group. Only comparative non-randomized studies were
available, further emphasizing the need for a prospective randomized trial comparing MITG and OTG.
Introduction
Gastric cancer is responsible for ten per cent of all cancer-
related deaths worldwide, with the highest incidence rates
in Eastern Asia, Eastern Europe, and South America [1].
Until this day, the only curative treatment for gastric cancer
is gastrectomy with adequate lymph node dissection [2]. As
(neo)-adjuvant therapy has proven to be successful, an
increasing number of patients are treated this way [3, 4]. In
recent years, minimally invasive techniques have gained
increasing interest in the treatment of gastric cancer. The
first reported minimally invasive distal gastrectomy was
performed in 1994 by Kitano et al. [5], followed in 1996 by
the first minimally invasive total gastrectomy for cancer by
Azagra et al. [6]. Since then, several studies, and meta-
analyses examined the safety and feasibility of minimally
invasive gastrectomy for cancer [7–9]. The outcomes of
these studies have shown promising results such as faster
recovery, less pain, shorter hospital stay, improved quality
of life after surgery, and above all equal outcomes of
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morbidity and mortality in comparison with open gastrec-
tomy [10]. Although the results are promising, the number
of studies was relatively small, their power was low, and no
difference was made between types of gastrectomy, but
mainly focused on distal gastrectomy or combined the
different types of gastrectomies, partial, total and/or prox-
imal [9–11]. Consequently, a heterogeneous study popu-
lation was created, and as a result, outcomes are not
transferable to an actual group of total gastrectomy patients
[7, 12, 13].
The aim of this study is to assess evidence for a mini-
mally invasive approach in total gastrectomy by comparing
MITG to OTG with respect to operative data, conversion
rate, postoperative data, morbidity and mortality, com-




To identify all relevant publications, a systematic search in
the bibliographic databases PubMed, EMBASE, and The
Cochrane Library (via Wiley) from inception to February
5th 2015 was performed. Search terms included controlled
terms from MeSH in PubMed, EMtree in EMBASE.com as
well as free text terms. Free text terms were only used in
The Cochrane library. Search terms expressing ‘stomach
neoplasms’ were used in combination with search terms
comprising ‘open surgery’ and ‘laparoscopy.’ The refer-
ence list of included articles was hand-searched for rele-
vant publications.
Selection criteria
Two authors (J.S. and N.W.) independently evaluated the
search findings for potential eligibility for this meta-anal-
ysis using the Medline, Embase, and Cochrane databases.
The inclusion criteria were as follows: (1.) Article pub-
lished in English language; (2.) Only full-text articles, no
abstracts, or case reports were included; and (3.) The study
had to compare minimally invasive total gastrectomy
(MITG) with open total gastrectomy (OTG) for cancer.
Definitions
Operation duration was defined in minutes, and blood loss
in milliliters. All studies reporting blood loss in grams were
not included in the analysis of this parameter. Hospital stay
and time to first flatus were reported in days. If studies
reported, these parameters in hours a conversion to days
would be made. Definitions of complications varied
between different studies, and there was no consensus in
reporting type or grade of complication such as the Cla-
vien-Dindo grading system for the classification of surgical
complications [14, 15]. Therefore, only the number of
complications was reported. In-hospital mortality was
defined as mortality within 30 days after surgery. Lymph
node yield was measured as the mean number of resected
lymph nodes with a standard deviation. Data regarding
mean resection margins were also collected along with
survival data. None of the studies reported neo-adjuvant
treatment.
Data extraction and quality assessment
The reviewers (J.S. and N.W.) extracted the following data
from each study: first author, title of the article, year of
publication, geographical region, type of study, type of
gastrectomy, type of reconstruction, TNM stage, number
of patients included, number of patients who underwent
open gastrectomy, number of patients who underwent
minimally invasive gastrectomy, operation duration, esti-
mated blood loss, time to first flatus, time to first oral
intake, length of hospital stay, percentage of postoperative
complications, and percentage of mortality. Moreover,
data concerning follow-up and survival were collected. All
the data were reported in means and standard deviation. If
the article did not report the parameters in means and
standard deviations, a request for this information was sent
to the concerning author and this information was received
from one author [16]. Due to the difficulty of receiving
raw data, the data from the published articles were used in
this meta-analysis. To assess the quality of the studies, all
reviewers classified the studies using the Newcastle-Ot-
tawa Quality Assessment Scale (NOS) for retrospective
cohort studies and case–control studies [17]. A maximum
of nine points could be awarded, four points for selection
criteria, two points for comparability, and three points for
outcome. Beforehand, the criteria were discussed between
the reviewers so an equal scoring method was used. In
case of doubt, deliberation was conducted between the
reviewers and the problem would be resolved with mutual
approval. Studies achieving six or more points would be
classified as high quality and were used for further anal-
ysis. Moreover, the level of evidence was assessed for
each study [18].
Statistical analysis
The meta-analysis was performed in line with the recom-
mendations from the PRISMA Statement for Reporting
Systematic Reviews and Meta-Analyses [19]. Review
Manager version 5.3.3 (2014) was used for data analyses,
as downloaded from the Cochrane Library. Continuous
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variables were assessed using the weighted mean differ-
ence. Dichotomous variables were assessed using the Odds
Ratio. To account for clinical heterogeneity, the random
effects model based on DerSimonian and Laird’s method




The literature search resulted in 1797 hits; after deleting
the duplicate articles, 1242 articles remained; Articles were
independently screened based on title and abstract by two
different authors (J.S. and N.W.) and a selection of 153
articles for full-text analysis remained. Fifty-seven articles
did not meet the pre-defined criteria after reading the full-
text. Via cross-referencing, an additional three articles
were added, thus resulting in 99 full-text articles regarding
laparoscopic versus open gastrectomy. The focus of this
meta-analysis was to analyze all studies regarding total
gastrectomy; therefore, we only included articles compar-
ing minimally invasive total gastrectomy with open total
gastrectomy. When the same author published more than
one study from an overlapping study period, the article
with the longest study period or largest cohort was included
in the analysis. This eventually resulted in twelve relevant
articles. A flow-chart of article selection is depicted in
Fig. 1.
Fig. 1 Flow-chart for selection
of articles
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Study characteristics
A total of ten retrospective cohort studies and two case–
control study were identified as suitable for analysis [16,
20–30]. The total number of patients included in these
studies was 1360, with 592 (43.5 %) patients who under-
went MITG and 768 (56.5 %) who underwent OTG. Five
studies reported that none of the minimally invasive pro-
cedures were converted to an open procedure; Lee et al.
reported four patients to be converted from minimally
invasive surgery to open surgery. However, these patients
were excluded from the study; other studies did not report
information regarding conversion rates [20, 21, 25, 27, 28,
30]. Nine out of 12 studies were conducted in Asian
countries (Japan, Korea and China) and three studies were
conducted in European countries (France, Italy and Bel-
gium). An overview of the included articles is depicted in
Table 1. Analysis of tumor stage according to TNM stage
or tumor size showed a significant difference in two studies
[25, 26]. Both studies reported a greater tumor size in the
open group.
Baseline characteristics were comparable in eleven
studies. Topal et al. reported in the article that baseline
characteristics were comparable; however, there was no
further information regarding these characteristics [16].
Thus, this study received one point for comparability due
to imprecise results. Other studies received only one point
due to the fact that the study did not correct for oncological
stage, which the researchers deemed to be an important
factor. An overview of attributed scores is portrayed in
Table 2.
Operative results
All studies described the mean operative time. The pro-
cedure was found to be significantly longer for the MITG
approach in all studies. The weighted mean difference was
48.06 min (95 % CI 30.75–65.38) and P\ 0.00001
(Fig. 2).
Ten out of twelve studies described estimated blood
loss. In all ten studies, blood loss was significantly less in
the MITG group. The weighted mean difference was
-160.70 mL (95 % CI -224.27 to -97.12 and
P\ 0.00001) (Fig. 2).
Postoperative recovery
Nine studies described the time to first flatus. The time to
first flatus was significantly shorter in the MITG group. All
studies showed a shorter time period to first flatus in the
minimally invasive group. The weighted mean difference
was -1.05 days (95 % CI -1.44 to -0.66) and
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Ten out of twelve studies described the length of hos-
pital stay. The duration of hospitalization was significantly
shorter in the MITG group. Two studies showed a mean
shorter hospital stay in the OTG group in comparison with
the MITG group [16, 28]. The weighted mean difference
was -2.43 days (95 % CI -3.71 to -1.16) and
P = 0.0002 (Fig. 3).
Morbidity and mortality
Ten studies report results of postoperative complications.
There were significantly less postoperative complications
in the group who underwent MITG. The odds ratio was
0.66 (95 % CI 0.47–0.93) and P\ 0.02 (Fig. 4). No dif-
ferentiation in type of complications was listed in the
included articles. Long-term follow-up data regarding
complications were not available in these studies.
Eight out of twelve studies stated 30-day mortality rates,
with four studies describing no mortality in both groups
[26, 27, 29, 30]. Two other studies [23, 24] did not report
mortality rates but did report postoperative complications.
There was no significant difference in mortality rates
between the MITG group and the OTG group. The odds
ratio was 0.60 (95 % CI 0.13–2.82) and P = 0.52 (Fig. 4).
Long-term survival
Long-term survival was reported in eight studies, ranging
from 2 to 180 months follow-up. No differences in survival
were reported between MITG and OTG in four studies that
analyzed survival [25, 27, 29, 30]. The other articles only
described survival data. Due to differences in follow-up
length, differences in analysis of survival, heterogeneity
between studies, and dispersion in follow-up data, pooled
analysis of survival data was not possible.
Completeness of oncological resection
Eleven out of twelve studies described the total number of
resected lymph nodes. There was no significant difference
between the two groups. The weighted mean difference
was -2.30 (95 % CI -4.73 to 0.14) and P = 0.06 (Fig. 5).
Eight studies showed a higher mean number of resected
lymph nodes in favor of the open group. None of the
articles provided information on the resected stations and
whether this is in accordance with a D1, D1?, or D2
lymphadenectomy.
Only three studies provided details regarding the extent
of distal and proximal resection margins. No significant
differences were observed in the resection margin between
the groups [20, 24, 29]. Additionally, three studies reported
results of resection radicality, of which two studies repor-
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reported two R1 resections, one in the open group and one
in the minimally invasive group; all other patients had R0
resections [16]. Thus, no significant difference was found
regarding radicality of the resection in both groups.
Discussion
The here presented meta-analysis aimed to assess the
optimal surgical technique in patients undergoing total
gastrectomy for cancer. The minimally invasive technique
was compared to the open approach. Based on these find-
ings, MITG was associated with less blood loss, a faster
postoperative recovery, and less postoperative morbidity
with similar mortality rates compared to OTG. Moreover,
completeness of oncological resection concerning the
number of lymph nodes resected was similar in both groups
indicating that minimally invasive total gastrectomy seems
to be non-inferior to open total gastrectomy in short-term
outcomes. No conclusions could be made concerning long-
term survival due to dispersion and inaccuracy of the dis-
posable data.
All studies included were non-randomized and retro-
spective of nature. Although the observational nature might
introduce bias, a meta-analysis of observational studies was
deemed feasible [31]. No differences in baseline charac-
teristics were observed in the included studies. All studies
included all different stages of disease. Only two studies
showed a significant difference in tumor size, where the
tumor was greater in the open group [25, 26]. Most studies
were conducted in Asian countries.
With exception of operative time, data concerning
operative blood loss and recovery of the patient are in favor
of the MITG group, indicating the reduced invasiveness of
the procedure. Increased experience with this type of
approach showed a clear decrease in operating time [32,
33].
This systematic review and meta-analysis assesses the
optimal surgical strategy for total gastrectomy in patients
with gastric cancer. Other systematic reviews and meta-
analyses included both total and subtotal gastrectomy or
regarded only laparoscopy-assisted techniques [9, 10].
Concerning the hospital stay, it should be noted that one
article reported all patients were routinely discharged at
Fig. 2 Forrest plot of comparison of operative data duration of operation (minutes) and peri-operative blood loss (ml)
World J Surg (2016) 40:148–157 153
123
postoperative day 14 [22]. This study was not included for
analysis of length of hospital stay. Another study stated the
final decision for discharge was left to the patient’s own
decision [24]. No definitions of discharge criteria were
provided in the other included studies. Therefore, no
assurance can be made for the quality of this outcome.
Along with a faster postoperative recovery, postopera-
tive complications were less prevalent in patients who
underwent MITG. Complications were not reported using
the Clavien-Dindo classification. Therefore, the grade of
complications, minor or major, could not be taken into
account in this meta-analysis. Also information on surgi-
cal and non-surgical complications was not provided.
Moreover, no results of long-term complications or
quality of life after surgery were described. Further
research is necessary in order to assess the effect of
minimally invasive techniques on Patient Reported Out-
come Measurements such as quality of life and cost-
effectiveness.
30-day mortality showed no significant differences. Data
for 30-day mortality were available from eight studies. The
question remains if mortality did not occur in the other
study groups, if it happened past postoperative day 30, or if
it was not measured at all.
The number of resected lymph nodes is considered a
marker for radicality, survival, and quality of care [34–36].
A novel surgical technique should be non-inferior with
regard to total lymph node resection and the distribution in
stations. The here presented meta-analysis showed no sig-
nificant difference in lymph node yield between MITG and
OTG. There is no adequate reference to their distribution
according to the Japanese classification [37]. Also infor-
mation on the number of patients that received routine
splenectomy was not available.
The results of the resection margin were only mentioned
in three studies [20, 24, 29]. Of even greater interest is the
long-term survival after both approaches with regard to
survival and disease-free survival. In this meta-analysis,
the analysis of long-term outcomes was not possible due to
the lack of available data, heterogeneity between studies
and dispersion in follow-up data. Therefore, no comparison
could be made regarding this outcome.
Fig. 3 Forrest plot of comparison of postoperative recovery; time to first flatus (days); hospital stay (days)
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Fig. 4 Forrest plot of comparison of morbidity with regard to postoperative complications and in-hospital mortality rates
Fig. 5 Forrest plot of comparison of number of resected lymph nodes
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Conclusion
With similar results in lymph node yield, faster postoper-
ative recovery, and less complications, the assumption may
be made that minimally invasive gastrectomy is non-infe-
rior to the open technique with regard to long-term
recovery and completeness of the resection. However,
resection margins and long-term survival data need to be
evaluated. All included studies were non-randomized and
retrospective of nature, which influences the quality of the
depicted outcomes. A prospective randomized trial is
indicated in order to establish the optimal surgical strategy
in total gastrectomy for patients with gastric cancer and is
currently underway from our department.
The primary outcome will be quality of oncological
resection, as measured by the number of nodes according to
the Japanese classification of gastric carcinoma, stating that
minimally invasive techniques should be non-inferior.
Lymph node stations are marked and analyzed separately
according to the Japanese gastric cancer treatment guide-
lines [2]. Secondary outcomes will be postoperative
recovery, hospital stay, morbidity and mortality, progres-
sion-free survival, overall survival, and quality of life [38].
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